IM Cannabis Corp. entered into a Note Purchase Agreement on July 1, 2026, to issue a US$225,000 convertible note and warrants to an institutional investor. The note bears an 8.0% annual interest rate and is convertible into common shares at a price determined by the lower of a fixed price of US$0.152 or a variable price based on 20-day VWAP, with a floor price of US$0.0303. The warrants allow the holder to purchase up to 1,483,386 common shares at an exercise price of CAD$0.22 per share. IM Cannabis Corp. operates in the medical cannabis industry, providing products for the Israel and Israel and Germany markets.
